Results 21 to 30 of about 864 (131)

Reforming the provision of cross‐border medical care: Evidence from Spain

open access: yesHealth Economics, Volume 31, Issue 5, Page 859-876, May 2022., 2022
Abstract Cross‐border medical care, defined as care facilitated by a local health provider under pre‐established regional agreements, as in the case of European Union (EU) citizens accessing care within EU countries, has been on the rise. Unlike medical tourism, typically sought by patients through their own volition and paid for out‐of‐pocket, cross ...
Catalina Amuedo‐Dorantes   +2 more
wiley   +1 more source

European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCAA and the EBSB working groups of the ESCD, and the GEIDACC

open access: yesContact Dermatitis, Volume 86, Issue 5, Page 379-389, May 2022., 2022
Abstract Background In 2019, a number of allergens (haptens), henceforth, “the audit allergens,” were considered as potential additions to the European Baseline Series (EBS), namely, sodium metabisulfite, 2‐bromo‐2‐nitropropane‐1,3‐diol, diazolidinyl urea, imidazolidinyl urea, Compositae mix II (2.5% or 5% pet), linalool hydroperoxides (lin‐OOH ...
Wolfgang Uter   +23 more
wiley   +1 more source

Desafíos de medición para la investigación de la obesidad infantil en y entre América Latina y Estados Unidos

open access: yesObesity Reviews, Volume 22, Issue S5, Octubre 2021., 2021
Resumen La obesidad infantil es un grave problema de salud pública en Latinoamérica y Estados Unidos y para luchar contra ella se precisan instrumentos de medición válidos y fiables y que tengan en cuenta los aspectos culturales. Para avanzar en este campo sería útil mejorar las mediciones en los distintos grupos de edades y países del continente ...
David Berrigan   +11 more
wiley   +1 more source

Sector farmacéutico y el registro sanitario de uno de sus productos estrella

open access: yesCatálogo editorial, 2022
La Compañía Transnacional Colombo-Peruana, con sede principal en Bogotá, hace parte del sector farmacéutico y pertenece a un grupo empresarial que se dedica a la comercialización, investigación y desarrollo de soluciones terapéuticas enfocadas a diferentes mercados de la salud de medicamentos. Esta empresa cuenta con presencia en más de cinco países en
Juan Sebastián Cubillos-Urrego   +5 more
openaire   +1 more source

Comparación de requisitos específicos para el registro sanitario de medicamentos biológicos en Centroamérica y República Dominicana

open access: yesRepertorio Científico, 2022
Introducción: Los medicamentos biológicos son productos que tienen como principios activos uno o más derivados de material biológico extraídos de fluidos, tejidos o microorganismos, mientras que los biotecnológicos se desarrollan a través de la tecnología de ADN recombinante con la implantación de material genético de genes pertenecientes a una especie
Daniela González Rodríguez   +3 more
openaire   +2 more sources

La regulación del registro sanitario de medicamentos en Panamá

open access: yesRevista Cathedra, 2019
En este documento se pretende establecer un juicio crítico de lo que existe en referencia a la Regulación de Registro Sanitario de Medicamentos, dándole inicialmente un enfoque desde el punto de vista del Derecho a la Salud, dentro del aspecto de la disponibilidad de medicamentos, abordando el concepto y definición de Registro Sanitario, el alcance ...
openaire   +1 more source

Patch Test Results With Additions to the European Baseline Series, 2021/22—Joint European Results of the ESSCAA and the EBSB Working Groups of the ESCD, and the GEIDACC

open access: yesContact Dermatitis, Volume 95, Issue 3, Page 276-285, September 2026.
ABSTRACT Background Allergens are periodically added to the European Baseline Series (EBS) to audit their value in consecutive patch testing. Objectives To present results of audit allergens tested in consecutive patients in 54 departments in 13 European countries during 2021 and 2022.
Wolfgang Uter   +68 more
wiley   +1 more source

Patch Test Results With the European Baseline Series, 2021/2022—Joint European Results of the ESSCAA and the EBSB Working Groups of the ESCD, and the GEIDACC

open access: yesContact Dermatitis, Volume 95, Issue 1, Page 17-32, July 2026.
ABSTRACT Background Patch test results obtained with the European Baseline Series (EBS) in its current version serve both contact allergy surveillance and (re‐)assessing the diagnostic value of EBS allergens. Objectives To present results of current EBS patch testing, obtained in 59 departments in 14 European countries during 2021 and 2022.
Wolfgang Uter   +73 more
wiley   +1 more source

Low‐intervention clinical trials in Spain: Do they progress?

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1438-1444, May 2026.
Abstract Aims Low‐Intervention Clinical Trials (LICTs) are generally pragmatic trials that investigate medicinal products already authorized for use. In 2014, simplified regulatory frameworks were introduced for LICTs with the aim of reducing regulatory burden and operational complexity, to foster non‐commercial clinical trials (NCCTs); the mandatory ...
Claudia Erika Delgado‐Espinoza   +4 more
wiley   +1 more source

Legal perspectives on black box recording devices in the operating environment

open access: yesBJS (British Journal of Surgery), Volume 106, Issue 11, Page 1433-1441, October 2019., 2019
A video and medical data recorder in the operating theatre is possible, but concerns over privacy, data use and litigation have limited widespread implementation. Transparency on the use and purpose of the recorded data should be ensured to both staff and patients. Clear legislation on data responsibility is needed to use the medical recorder optimally
A. S. H. M. van Dalen   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy